Mok TS - Search Results

1

Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong Kong.

Hui EP, Leung LK, Mo F, Chan VT, Ma AT, Poon A, Hui EK, Mak SS, Lai M, Lei KI, Ma BB, Mok TS, Yeo W, Zee B, Chan AT. Hui EP, et al. Among authors: mok ts. Hong Kong Med J. 2010 Jun;16 Suppl 3:34-7. Hong Kong Med J. 2010. PMID: 20601732 Free article. No abstract available.

2

Adequate lymph node staging is fundamental to comparative study on resectable non-small-cell lung cancer.

Mok TS, Zee B. Mok TS, et al. J Clin Oncol. 2002 May 15;20(10):2604-5; author reply 2605. doi: 10.1200/JCO.2002.20.10.2604. J Clin Oncol. 2002. PMID: 12011141 No abstract available.

3

Quantification and utility of monosialylated alpha-fetoprotein in the diagnosis of hepatocellular carcinoma with nondiagnostic serum total alpha-fetoprotein.

Poon TC, Mok TS, Chan AT, Chan CM, Leong V, Tsui SH, Leung TW, Wong HT, Ho SK, Johnson PJ. Poon TC, et al. Among authors: mok ts. Clin Chem. 2002 Jul;48(7):1021-7. Clin Chem. 2002. PMID: 12089170

4

Phase II study of docetaxel and epirubicin in Chinese patients with metastatic breast cancer.

Yeo W, Mok TS, Tse KK, Kwan WH, Lam KC, Ho WM, Chiu SK, Chan AT, Leung TW, Mo FK, Johnson PJ. Yeo W, et al. Among authors: mok ts. Anticancer Drugs. 2002 Jul;13(6):655-62. doi: 10.1097/00001813-200207000-00013. Anticancer Drugs. 2002. PMID: 12172512 Clinical Trial.

5

A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.

Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P. Mok TS, et al. Cancer. 2002 Oct 1;95(7):1511-9. doi: 10.1002/cncr.10836. Cancer. 2002. PMID: 12237920 Free article. Clinical Trial.

6

Unusual abdominal tumors: case 4. Multiple lymphomatous polyposis in mantle cell lymphoma.

Lam KC, Yeo W, Lee JF, Chow J, Mok TS. Lam KC, et al. Among authors: mok ts. J Clin Oncol. 2003 Mar 1;21(5):955-6. doi: 10.1200/JCO.2003.11.124. J Clin Oncol. 2003. PMID: 12610203 No abstract available.

7

Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.

Poon TC, Yip TT, Chan AT, Yip C, Yip V, Mok TS, Lee CC, Leung TW, Ho SK, Johnson PJ. Poon TC, et al. Among authors: mok ts. Clin Chem. 2003 May;49(5):752-60. doi: 10.1373/49.5.752. Clin Chem. 2003. PMID: 12709366

8

A prospective study of pre-treatment cell kinetics and clinical outcome in nasopharyngeal carcinoma.

Hui EP, Poon TC, Teo PM, Mo F, Zee B, Leung SF, Ho S, Mok TS, Kwan WH, Johnson PJ, Chan AT. Hui EP, et al. Among authors: mok ts. Radiother Oncol. 2003 Oct;69(1):53-62. doi: 10.1016/s0167-8140(03)00248-2. Radiother Oncol. 2003. PMID: 14597357

9

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

Yeo W, Chan PK, Ho WM, Zee B, Lam KC, Lei KI, Chan AT, Mok TS, Lee JJ, Leung TW, Zhong S, Johnson PJ. Yeo W, et al. Among authors: mok ts. J Clin Oncol. 2004 Mar 1;22(5):927-34. doi: 10.1200/JCO.2004.05.161. J Clin Oncol. 2004. PMID: 14990649 Clinical Trial.

10

A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer.

Mok TS, Leung TW, Brown G, Moyses C, Chan AT, Yeo W, Wong H, Chak K, Johnson P. Mok TS, et al. Acta Oncol. 2004;43(3):245-51. doi: 10.1080/02841860310023525. Acta Oncol. 2004. PMID: 15244247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters